Enovis Sells Dr. Comfort: A Step in the Right Direction?
Update: 2025-10-08
Description
Enovis Corp. stock jumps 4% after selling its Dr. Comfort shoe business for a potential $60 million, allowing them to refocus on core prevention and recovery tech and reduce debt. While a positive sign, Enovis faces ongoing challenges, including a recent US government investigation into medical device imports, contributing to a volatile year with the stock down 29% since January. Is this sale enough to revive investor confidence?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
